Paper39655168
Evaluation of intranasal TLR2/6 agonist INNA-051: safety, tolerability and proof of pharmacology.
Mercuri FA and 12 others. ERJ Open Res, 2024. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Evaluation of intranasal TLR2/6 agonist INNA-051: safety, tolerability and proof of pharmacology. Papers, record 39655168. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39655168
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation of intranasal TLR2/6 agonist INNA-051: safety, tolerability and proof of pharmacology.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20943654 | Transcription factor redundancy ensures induction of the antiviral state. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20943654 | PubMed |
| 2 | 12184808 | Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. | Genome Biol | 2002 | https://conductscience.org/library/papers/12184808 | PubMed |
| 3 | 29651984 | IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission. | Elife | 2018 | https://conductscience.org/library/papers/29651984 | PubMed |
| 4 | 25605792 | limma powers differential expression analyses for RNA-sequencing and microarray studies. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/25605792 | PubMed |
| 5 | 32056049 | Influenza and antiviral resistance: an overview. | Eur J Clin Microbiol Infect Dis | 2020 | https://conductscience.org/library/papers/32056049 | PubMed |
| 6 | 29920501 | Distinct Gene Expression Patterns between Nasal Mucosal Cells and Blood Collected from Allergic Rhinitis Sufferers. | Int Arch Allergy Immunol | 2018 | https://conductscience.org/library/papers/29920501 | PubMed |
| 7 | 23355384 | Compromised respiratory function in lethal influenza infection is characterized by the depletion of type I alveolar epithelial cells beyond threshold levels. | Am J Physiol Lung Cell Mol Physiol | 2013 | https://conductscience.org/library/papers/23355384 | PubMed |
| 8 | 34678117 | Host factors subverted by Mycobacterium tuberculosis: Potential targets for host directed therapy. | Int Rev Immunol | 2023 | https://conductscience.org/library/papers/34678117 | PubMed |
| 9 | 26611907 | The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma. | Ther Adv Respir Dis | 2016 | https://conductscience.org/library/papers/26611907 | PubMed |
| 10 | 33376754 | Associations Between Relative Viral Load at Diagnosis and Influenza A Symptoms and Recovery. | Open Forum Infect Dis | 2020 | https://conductscience.org/library/papers/33376754 | PubMed |
| 11 | 30953061 | Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine Development. | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/30953061 | PubMed |
| 12 | 27350884 | Toll-like receptors: the swiss army knife of immunity and vaccine development. | Clin Transl Immunology | 2016 | https://conductscience.org/library/papers/27350884 | PubMed |
| 13 | 23361009 | Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. | Nat Commun | 2013 | https://conductscience.org/library/papers/23361009 | PubMed |
| 14 | 35387020 | TLR Signals in Epithelial Cells in the Nasal Cavity and Paranasal Sinuses. | Front Allergy | 2021 | https://conductscience.org/library/papers/35387020 | PubMed |
| 15 | 24866471 | The epidemiology and spread of drug resistant human influenza viruses. | Curr Opin Virol | 2014 | https://conductscience.org/library/papers/24866471 | PubMed |
| 16 | 30450666 | Recent clinical trends in Toll-like receptor targeting therapeutics. | Med Res Rev | 2019 | https://conductscience.org/library/papers/30450666 | PubMed |
| 17 | 26933507 | Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848. | BMJ Open Respir Res | 2016 | https://conductscience.org/library/papers/26933507 | PubMed |
| 18 | 29443104 | Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples. | J Vis Exp | 2018 | https://conductscience.org/library/papers/29443104 | PubMed |
| 19 | 35832809 | Toll-Like Receptor Signaling in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Innate Immune Responses and the Potential Application Value of Toll-Like Receptor Immunomodulators in Patients With Coronavirus Disease 2019. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35832809 | PubMed |
| 20 | 9431281 | The impact of influenza epidemics on mortality: introducing a severity index. | Am J Public Health | 1997 | https://conductscience.org/library/papers/9431281 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42972013 | Towards anti-influenza nasal sprays: infection models and opportunities to reduce animal testing. | Npj Viruses | 2026 | https://conductscience.org/library/papers/42972013 | PubMed |
| 42548815 | Mucosal immune cell priming by intranasally delivered Haemophilus haemolyticus is associated with heterologous protection against influenza and nontypeable Haemophilus influenzae. | Front Immunol | 2026 | https://conductscience.org/library/papers/42548815 | PubMed |
| 41853276 | Targeting Toll-like Receptor 2: synthetic diacylated lipopeptides polarize equine macrophages towards a pro-inflammatory phenotype. | Front Immunol | 2026 | https://conductscience.org/library/papers/41853276 | PubMed |
| 41282602 | Association between point mutations of macrolide-resistant Mycoplasma pneumoniae and clinical antibiotic treatment efficacy: a meta-analysis. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41282602 | PubMed |
| 41158497 | Priming mucosal pathogen-agnostic innate immunity with an intranasal TLR2/6 agonist in an aged population. | ERJ Open Res | 2025 | https://conductscience.org/library/papers/41158497 | PubMed |
| 41060047 | Prophylactic Efficacy of CD388, a Novel Drug-Fc Conjugate, in a Human Influenza A/H3N2 Virus Challenge Model: A Randomized, Controlled Phase 2a Study. | Clin Infect Dis | 2025 | https://conductscience.org/library/papers/41060047 | PubMed |
| 40299084 | Efficacy and Safety of Fexuprazan Versus Esomeprazole for Gastroesophageal Reflux Disease-Related Chronic Cough: A Randomized, Double-Blind, Active-Controlled Exploratory Trial. | Lung | 2025 | https://conductscience.org/library/papers/40299084 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39655168
GET https://conductscience.org/api/papers/v1/39655168/references?page=2